This site is intended only for healthcare professionals residing in Singapore

Search

Menu

Close

Sign InLog Out Our medicinesTherapy areasExplore contentExplore contentEventsMaterialsVideosLet’s connectLet's ConnectContact usPfizer medical information
Acute Lymphoblastic Leukemia Acute Myeloid Leukemia
Acute Myeloid Leukemia (AML)

Acute myeloid leukemia (AML) is a heterogeneous hematologic malignancy characterized by the clonal expansion of myeloid blasts in the peripheral blood, bone marrow, and/or other tissues1. 

Acute Myeloid Leukemia 

Embark on a journey to learn more about the management of AML through a wide range of resources including clinical data and downloadable treatment management materials.

 Learn more
Reference:1. NCCN Guidelines Version 3.2022 Acute Myeloid Leukemia
PP-INO-SGP-0118/02MAR2023
PfizerPro AccountPfizerPro Account

To access further materials, resources and receive communication about medicines and vaccines promoted by Pfizer.

Sign inRegisterAccountSign Out

The information provided in this site is intended only for Healthcare Professionals in Singapore. The products discussed herein may have different product labelling in different countries. Pfizer Pte Ltd, Singapore is a subsidiary of Pfizer Inc, a pharmaceutical company committed to helping people improve their health by discovering and developing medicines.
 

Copyright © 2023 Pfizer Limited. All rights reserved.
You are now leaving the website
You are now leaving a Pfizer-operated website. Links to all outside sites are provided as a resource to our visitors. Pfizer accepts no responsibility for the content of sites that are not owned and operated by Pfizer.